Cortava

Curated by Signal

Developer of transcranial electrotherapy stimulation device

Overview

Developer of transcranial electrotherapy stimulation device. The company offers transcranial direct current stimulation device to modulate brain activity as well as potentially improve cognitive, sensory, and motor functions in individuals and those with various neurological and psychiatric conditions.

Key facts

Founded: 2020
Headquarters: Corvallis, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Pro-Testing Solutions
Online platform offering screening and testing solutions for the community
Health TechnologyCoeur d Alene, United States
AppwoRx
Patient engagement apps
Health TechnologyAventura, United States
HealthAppy Tech
Mobile app for epilepsy management
Health TechnologyAtlanta, United States

About Cortava

What does Cortava do?

Developer of transcranial electrotherapy stimulation device.

Where is Cortava headquartered?

Cortava is headquartered in Corvallis, United States.

When was Cortava founded?

Cortava was founded in 2020.

Which sector is Cortava in?

Cortava operates in Health Technology.

Who are Cortava's competitors?

Companies similar to Cortava include Pro-Testing Solutions, AppwoRx, and HealthAppy Tech.